A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers
Inclusion Criteria
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
- Opportunistic infections or Kaposi's sarcoma.
- Critical illness.
- History of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric
ulcer.
Concurrent Medication:
Excluded:
- Steroids.
- Cytotoxic immunosuppressive agents.
Concurrent Treatment:
Excluded:
- Radiotherapy.
The following are excluded:
- Opportunistic infections or Kaposi's sarcoma.
- Critically ill patients.
- Patients receiving steroids, cytotoxic immunosuppressive agents, and/or radiotherapy.
- Patients who have received any other immunotherapy.
- Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction,
and severe gastric ulcer.
Prior Medication:
Excluded:
- Any other immunotherapy.
Patients who fall into the group which is at risk of developing cutaneous sarcoma and/or
opportunistic diseases but at present have no signs or symptoms of these diseases.